Sign in

CIK 0000882796

  • Large accelerated filer

BIOCRYST PHARMACEUTICALS INC

Sign in to watch
Ticker
BCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
621413174
Phone
+1 919-859-1302
Business address
4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-06-13 LEE KENNETH B JR Director Grant or award +16,745 68,863
2023-06-13 LEE KENNETH B JR Director Grant or award · Automatic Stock Option Grant +39,072 39,072
2023-01-31 LEE KENNETH B JR Director Exercise or conversion +15,000 $1.71 $26K 52,118
2023-01-31 LEE KENNETH B JR Director Exercise or conversion · Automatic Stock Option Grant −15,000 0
2022-06-07 LEE KENNETH B JR Director Grant or award +12,866 37,118
2022-06-07 LEE KENNETH B JR Director Grant or award · Automatic Stock Option Grant +30,022 30,022
2021-09-13 LEE KENNETH B JR Director Exercise or conversion +15,000 $3.22 $48K 30,252
2021-09-13 LEE KENNETH B JR Director Sale −6,000 $15.35 $92K 24,252
2021-09-13 LEE KENNETH B JR Director Exercise or conversion · Automatic Stock Option Grant −15,000 0
2021-05-25 LEE KENNETH B JR Director Grant or award · Automatic Stock Option Grant +40,000 40,000
2020-05-12 LEE KENNETH B JR Director Grant or award · Automatic Stock Option Grant +40,000 40,000
2019-11-18 LEE KENNETH B JR Director Purchase +5,000 $1.45 $7K 15,252
2019-05-29 LEE KENNETH B JR Director Grant or award · Automatic Stock Option Grant +30,000 30,000
2018-06-20 LEE KENNETH B JR Director Grant or award · Automatic Stock Option Grant +30,000 30,000

Page 1 of 1 · 14 trades